Zhengzhou Bairui Animal Pharmaceutical Co., Ltd (Brand Name BORY) was established in September of 2005 with registered capital of USD 8 million, the manufacturing site is located at North of Yanhuang Road, Air Harbor District, Zhengzhou City, China. The site covers a total area of 35,000 m2 which includes workshops of powder & premix; injection; powder injection; oral solution; tablets; granules; herb drug extract and disinfectant. All of the products are manufactured under strict quality control procedures in Good manufacturing Practices (GMP) certified production facilities. BORY's annual sales of domestic market has reached over USD 20 million in 2015, which has become one of the top animal drug producers in China.
BORY's competitive advantage is forged by focusing on technology development and continuous efforts of innovation, company has an independent research institute with five laboratories and world class scientists which helps BORY to best responding the market needs. And to ensure the product quality, BORY's comprehensive quality management system also plays a key role to make sure GMP standards are executed in strict rotation. BORY believes that excellent quality is the foundation of continuous growing and sustainable development, which is also defining what BORY is all about.
